- Home
- PSQH vs TLSI Comparison
PSQH vs TLSI Comparison
Compare PSQH & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSQH
- TLSI
- Stock Information
- Founded
- PSQH 2021
- TLSI 2010
- Country
- PSQH United States
- TLSI United States
- Employees
- PSQH N/A
- TLSI N/A
- Industry
- PSQH Advertising
- TLSI Medical Specialities
- Sector
- PSQH Consumer Discretionary
- TLSI Health Care
- Exchange
- PSQH Nasdaq
- TLSI Nasdaq
- Market Cap
- PSQH 182.0M
- TLSI 158.0M
- IPO Year
- PSQH N/A
- TLSI N/A
- Fundamental
- Price
- PSQH $3.88
- TLSI $5.35
- Analyst Decision
- PSQH Strong Buy
- TLSI Strong Buy
- Analyst Count
- PSQH 2
- TLSI 6
- Target Price
- PSQH $5.75
- TLSI $11.75
- AVG Volume (30 Days)
- PSQH 1.4M
- TLSI 30.0K
- Earning Date
- PSQH 03-13-2025
- TLSI 03-27-2025
- Dividend Yield
- PSQH N/A
- TLSI N/A
- EPS Growth
- PSQH N/A
- TLSI N/A
- EPS
- PSQH N/A
- TLSI N/A
- Revenue
- PSQH $18,738,575.00
- TLSI $26,891,000.00
- Revenue This Year
- PSQH $320.91
- TLSI $60.90
- Revenue Next Year
- PSQH $68.09
- TLSI $53.73
- P/E Ratio
- PSQH N/A
- TLSI N/A
- Revenue Growth
- PSQH 482.62
- TLSI 67.90
- 52 Week Low
- PSQH $2.00
- TLSI $3.50
- 52 Week High
- PSQH $7.77
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- PSQH 43.93
- TLSI 61.45
- Support Level
- PSQH $3.71
- TLSI $4.80
- Resistance Level
- PSQH $4.15
- TLSI $5.33
- Average True Range (ATR)
- PSQH 0.40
- TLSI 0.32
- MACD
- PSQH -0.08
- TLSI 0.01
- Stochastic Oscillator
- PSQH 12.06
- TLSI 70.09
About PSQH PSQ Holdings Inc.
PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. The primary mission of the platform is to help consumers "shop their values" and put purpose behind purchases. It has two reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.